236 related articles for article (PubMed ID: 29494553)
1. Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.
Le Nail LR; Brennan M; Rosset P; Deschaseaux F; Piloquet P; Pichon O; Le Caignec C; Crenn V; Layrolle P; Hérault O; De Pinieux G; Trichet V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29494553
[TBL] [Abstract][Full Text] [Related]
2. Cancer-associated mesenchymal stroma fosters the stemness of osteosarcoma cells in response to intratumoral acidosis via NF-κB activation.
Avnet S; Di Pompo G; Chano T; Errani C; Ibrahim-Hashim A; Gillies RJ; Donati DM; Baldini N
Int J Cancer; 2017 Mar; 140(6):1331-1345. PubMed ID: 27888521
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion.
Cortini M; Massa A; Avnet S; Bonuccelli G; Baldini N
PLoS One; 2016; 11(11):e0166500. PubMed ID: 27851822
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.
Brune JC; Tormin A; Johansson MC; Rissler P; Brosjö O; Löfvenberg R; von Steyern FV; Mertens F; Rydholm A; Scheding S
Int J Cancer; 2011 Jul; 129(2):319-30. PubMed ID: 20878957
[TBL] [Abstract][Full Text] [Related]
5. High CD49f expression is associated with osteosarcoma tumor progression: a study using patient-derived primary cell cultures.
Penfornis P; Cai DZ; Harris MR; Walker R; Licini D; Fernandes JD; Orr G; Koganti T; Hicks C; Induru S; Meyer MS; Khokha R; Barr J; Pochampally RR
Cancer Med; 2014 Aug; 3(4):796-811. PubMed ID: 24802970
[TBL] [Abstract][Full Text] [Related]
6. Generation of Osteosarcomas from a Combination of Rb Silencing and c-Myc Overexpression in Human Mesenchymal Stem Cells.
Wang JY; Wu PK; Chen PC; Lee CW; Chen WM; Hung SC
Stem Cells Transl Med; 2017 Feb; 6(2):512-526. PubMed ID: 28191765
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
[TBL] [Abstract][Full Text] [Related]
8. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
[TBL] [Abstract][Full Text] [Related]
9. Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways.
Cleton-Jansen AM; Anninga JK; Briaire-de Bruijn IH; Romeo S; Oosting J; Egeler RM; Gelderblom H; Taminiau AH; Hogendoorn PC
Br J Cancer; 2009 Dec; 101(11):1909-18. PubMed ID: 19888226
[TBL] [Abstract][Full Text] [Related]
10. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.
Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patané S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
J Bone Miner Res; 2012 Jun; 27(6):1322-34. PubMed ID: 22367914
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.
Martins-Neves SR; Lopes ÁO; do Carmo A; Paiva AA; Simões PC; Abrunhosa AJ; Gomes CM
BMC Cancer; 2012 Apr; 12():139. PubMed ID: 22475227
[TBL] [Abstract][Full Text] [Related]
12. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model.
Tsukamoto S; Honoki K; Fujii H; Tohma Y; Kido A; Mori T; Tsujiuchi T; Tanaka Y
Int J Oncol; 2012 Jan; 40(1):163-9. PubMed ID: 21971610
[TBL] [Abstract][Full Text] [Related]
14. ROCK Inhibition Induces Terminal Adipocyte Differentiation and Suppresses Tumorigenesis in Chemoresistant Osteosarcoma Cells.
Takahashi N; Nobusue H; Shimizu T; Sugihara E; Yamaguchi-Iwai S; Onishi N; Kunitomi H; Kuroda T; Saya H
Cancer Res; 2019 Jun; 79(12):3088-3099. PubMed ID: 30992323
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy.
Sarhadi VK; Daddali R; Seppänen-Kaijansinkko R
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681692
[TBL] [Abstract][Full Text] [Related]
16. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
[TBL] [Abstract][Full Text] [Related]
17. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications.
Zheng Y; Wang G; Chen R; Hua Y; Cai Z
Stem Cell Res Ther; 2018 Jan; 9(1):22. PubMed ID: 29386041
[TBL] [Abstract][Full Text] [Related]
19. Increased invasiveness of osteosarcoma mesenchymal stem cells induced by bone-morphogenetic protein-2.
Yang X; Wang YP; Liu FX; Zeng K; Qian MQ; Chen G; Shi L; Zhu GX
In Vitro Cell Dev Biol Anim; 2013 Apr; 49(4):270-8. PubMed ID: 23519562
[TBL] [Abstract][Full Text] [Related]
20. Tumour stromal cells derived from paediatric malignancies display MSC-like properties and impair NK cell cytotoxicity.
Johann PD; Vaegler M; Gieseke F; Mang P; Armeanu-Ebinger S; Kluba T; Handgretinger R; Müller I
BMC Cancer; 2010 Sep; 10():501. PubMed ID: 20858262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
